Skip to content

Clinical outcomes of sleep-wake disorders and the relationship between comorbidities in the real world

Clinical outcomes of sleep-wake disorders and the relationship between comorbidities in the real world

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300071730
Enrollment
Unknown
Registered
2023-05-23
Start date
2023-06-01
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Disorders

Interventions

Experimental group (Sleep disorders treatment):None

Sponsors

Tangdu Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 90 Years

Inclusion criteria

Inclusion criteria: All patients with clinically suspected sleep-wake disorders could complete various scale assessments and sleep examinations according to clinical requirements.

Exclusion criteria

Exclusion criteria: 1. Patients who could not complete the self-assessment questionnaire; 2. Patients who refused the study; 3. The investigators considered that there were circumstances that made participation in the study inappropriate.

Design outcomes

Primary

MeasureTime frame
Pittsburgh Sleep Quality Index Score;International Restless Leg Syndrome Assessment Scale;REM sleep behavior disorder questionnaire - Hong Kong;Sleep Habit Scale;Sleep Personal Beliefs and Attitudes Scale;

Secondary

MeasureTime frame
Insomnia Severity Index;Epworth Sleepiness Scale Score;Morningness-Eveningness Questionnaire;Fatigur Scale-14;Self-Rating Scale of Sleep;Ulanlinna narcolepsy scale;Sudden fall severity questionnaire;Episodic Sleep Disorder Severity Scale;Stop Bang Scale;NREM related abnormal sleep assessment scale;Frontal Lobe Epilepsy and Abnormal Sleep Scale;

Countries

China

Contacts

Public ContactSu Changjun

Tangdu Hospital

changjunsu@163.com+86 139 9138 7356

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026